Our mission is to conduct innovative research, building bridges between innovative research methods and clinical practice. We do this in the Academic Collaborative Center Addiction within four lines of research. Innovation in healthcare and implementation is central to some lines of research; within other research lines there is more emphasis on (fundamental) research.
- Effects of new treatment methods for addiction, for example the treatment of addiction and comorbid problems.
- Basic/experimental research, focusing on the mechanisms of action of addiction.
- Mechanisms and implementation of E-Health
- Innovations in healthcare and healthcare research. Improvements in care, such as policy research, evaluation of standard care and the use of routine outcome management (ROM).
The Academic Collaborative Center Addiction Arkin/Jellinek is embedded in the research institute: Amsterdam Institute for Addiction Research (AIAR). We collaborate with the Department of Psychiatry Amsterdam UMC, as well as various other universities and institutions. AIAR’s knowledge network focuses on innovation, research, and implementation in addiction care. At AIAR, innovation and clinical practice go hand in hand to disseminate knowledge on addiction both nationally and internationally. This Academic Collaborative Center started in 2012, and in 2014, Jellinek was awarded the TOPGGz certificate as the first care facility for addiction.
Our mission is clear: to conduct pioneering research and building bridges between innovative research methodologies and clinical practice. Our four research lines are dedicated to improving care and expanding knowledge;
- Addiction prevention: This research line involves close collaboration with Jellinek Prevention
- Digitalisation: We investigate digital health and AI as a response to workforce shortages and strive for advanced digital solutions
- Addiction target groups and comorbidity: Through close cooperation with other Academic Workplaces within Arkin, we focus on understanding and treating complex psychiatric morbidity
- Treatment and aftercare: This line contributes to providing the most effective treatment for every patient.’
Team members
prof. dr. Anneke Goudriaan Principal Investigator
Nathalie Faber PhD student
Marissa de Vries PhD student
Lisa Imhoff PhD student
Christin Kühner PhD student
Rob van Alphen PhD student
Judith Noijen PhD student
Maartje van Lakerveld PhD student
Sera Lortye PhD student
Melissa Begeman Research coordinator and junior researcher
dr. Marleen de Waal Senior researcher
dr. Matthijs Blankers Senior researcher
